Observational study reports gastrointestinal toxicity in small dogs treated with vinblastine, indicating caution is necessary.
Vinblastine administered at a dosage of 2.0 mg/m2 in small dogs with malignant tumors resulted in gastrointestinal toxicity within clinically acceptable limits, but close monitoring for neutropenia is warranted. These findings suggest that dose escalation of VBL, as reported in larger dogs, may not be feasible in smaller dogs.
No takes yet. Share an insight, caveat, or question.
Matsuyama et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: